Risk Factors Update Summary
- Accumulated deficit increased from approximately $45 million in 2022 to $53 million in 2023.
- The company's ability to raise capital is impacted by disruptions in the global economy and supply chains.
- The company incurred net losses of approximately $9 million in 2023, compared to $7.6 million in 2022.
- Future funding requirements are now disclosed under Note 44 instead of Note 33.
- Cash and cash equivalents increased from $6 million in 2022 to $7.2 million in 2023.
- The company decided not to devote further financial resources to a specific indication for DMT310.
- Estimated cash to fund operations extended from the third quarter of 2023 to the third quarter of 2024.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1853816&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.